MAITREYA MEDICARE Stock Price Today (NSE: MAITREYA)
Fundamental Score
MAITREYA MEDICARE Share Price — Live NSE/BSE Price, Fundamentals & Analysis
MAITREYA MEDICARE share price today is ₹120.50, up +1.86% on NSE/BSE as of 1 September 2026. MAITREYA MEDICARE (MAITREYA) is a Small-cap company in the Hospital sector with a market capitalisation of ₹83.34 (Cr). The 52-week high for MAITREYA share price is ₹292.95 and the 52-week low is ₹107.50. The company has a Return on Equity (ROE) of -8.86% and a debt-to-equity ratio of 0.80.
MAITREYA MEDICARE Share Price Chart — NSE/BSE Historical Performance
MAITREYA MEDICARE share price chart: -5.71% return over the past month. 52-week high ₹292.95, 52-week low ₹107.50.
MAITREYA MEDICARE — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹120.95 | ₹126.85 | ₹119.30 | ₹120.50 | 5.20K (Cr) | |
| ₹111.50 | ₹120.95 | ₹110.35 | ₹118.30 | 8.40K (Cr) | |
| ₹120.30 | ₹128.00 | ₹110.05 | ₹113.70 | 6.80K (Cr) | |
| ₹130.00 | ₹130.00 | ₹115.55 | ₹118.95 | 2.40K (Cr) | |
| ₹125.00 | ₹125.00 | ₹116.90 | ₹116.90 | 2.40K (Cr) | |
| ₹114.95 | ₹117.60 | ₹112.25 | ₹112.25 | 2.40K (Cr) | |
| ₹117.30 | ₹117.30 | ₹111.55 | ₹112.85 | 1.60K (Cr) | |
| ₹118.50 | ₹118.50 | ₹118.50 | ₹118.50 | 400.00 (Cr) | |
| ₹111.90 | ₹111.90 | ₹111.00 | ₹111.00 | 800.00 (Cr) | |
| ₹116.00 | ₹117.20 | ₹110.00 | ₹110.50 | 10.40K (Cr) |
MAITREYA MEDICARE — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹120.95 | ₹126.85 | ₹119.30 | ₹120.50 | -0.37% | |
| ₹120.45 | ₹134.25 | ₹110.00 | ₹118.30 | -1.78% | |
| ₹148.00 | ₹148.00 | ₹107.50 | ₹127.00 | -14.19% | |
| ₹163.15 | ₹163.15 | ₹163.15 | ₹163.15 | +0.00% | |
| ₹174.00 | ₹187.85 | ₹161.65 | ₹164.80 | -5.29% | |
| ₹184.05 | ₹195.00 | ₹161.00 | ₹180.60 | -1.87% | |
| ₹185.10 | ₹205.00 | ₹162.05 | ₹176.50 | -4.65% | |
| ₹206.00 | ₹215.00 | ₹191.60 | ₹200.00 | -2.91% | |
| ₹213.75 | ₹244.00 | ₹190.90 | ₹192.40 | -9.99% | |
| ₹247.50 | ₹268.50 | ₹200.00 | ₹218.90 | -11.56% | |
| ₹247.00 | ₹292.95 | ₹225.90 | ₹256.60 | +3.89% | |
| ₹232.00 | ₹267.00 | ₹224.30 | ₹237.00 | +2.16% |
AI Research Briefing
Powered by Gemini · 2026-04-09
Maitreya Medicare's financials are deteriorating rapidly, and the market's growth expectations are detached from reality.
WHAT'S HAPPENING NOW
Maitreya Medicare reported a concerning set of quarterly results on April 2, 2026. Net profit plummeted to ₹-1.07 crore, a 167.72% QoQ decrease and a staggering 146.52% YoY decline. While revenue saw a slight 5.12% QoQ increase to , operating profit tanked by 137.05% QoQ to ₹-0.93 crore.
CORE STORY
Maitreya Medicare is being priced as a high-growth turnaround story in the SME hospital space, despite its micro-cap nature and recent poor performance. The market seems to be overlooking current financial struggles, focusing instead on potential future expansion and service offerings.
- Upcoming Valsad hospital
- Expansion into 18 specialities
- Micro-cap turnaround story
- Successful commissioning of Valsad hospital
- Significant increase in bed occupancy rates
- Attainment of profitability in next two quarters
- Micro-cap liquidity risk
- Extremely high P/E ratio
- Negative free cash flow
- Recent massive profit decline
FII holdings decreased by 0.01% [cite: brief]
The Indian hospital sector is growing, but faces increasing cost pressures and regulatory scrutiny.
No - Free Cash Flow 5Y: ₹-0.26 Cr [cite: brief]
The next 6 months will be critical to see if the company can turn around its performance. Without significant improvement, the stock is likely to underperform.
Primary Thesis Risk
Inability to achieve profitability and manage working capital will lead to collapse.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
MAITREYA MEDICARE Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
MAITREYA MEDICARE Fundamental Analysis & Valuation Benchmarking
Educational evaluation of MAITREYA across key market metrics for learning purposes.
Positive Indicators
3 factors identified
Healthy Liquidity Position (Current Ratio: 2.00)
Observation: Strong short-term liquidity to meet obligations.
Analysis: Current ratio >1.5 indicates good working capital management.
Balanced Promoter Holding (73.11%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
9 factors identified
Below-Average Return on Equity (-8.86%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (-2.18%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
High Price-to-Book Ratio (5.68x)
Observation: Trading at significant premium to book value.
Analysis: High P/B ratios may indicate overvaluation relative to asset base.
Profit Decline Concern (-1720.00%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Revenue Contraction (-5.16%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Limited Growth History (-4.32% CAGR)
Observation: Below-average 5-year sales growth trajectory.
Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.
Weak Interest Coverage (-0.67x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability.
Negative Free Cash Flow (₹-17.72 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
MAITREYA MEDICARE vs Hospital Peers
Peer Comparison - Hospital
Compare MAITREYA MEDICARE with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
6.9/100 | ₹120.50₹121 | ₹83.34₹83.34 | — — | -8.86%Poor -8.86% Poor | -2.18%Poor -2.18% Poor | 0.80Good 0.8 Good | — — | -4.32%Poor -4.32% Poor | 0.00% | |
Apollo Hospitals Enterprise LimitedApollo Hospital... APOLLOHOSP • 508869 | 62.1/100 | ₹8889.00₹8889 | ₹128448.55₹128448.55 | 61.47Average 61.5 Average | 21.95%Excellent 21.95% Excellent | 19.28%Good 19.28% Good | 0.60Good 0.6 Good | 66.81%Excellent 66.81% Excellent | 19.03%Excellent 19.03% Excellent | 0.22% |
Max Healthcare Institute LimitedMax Healthcare ... MAXHEALTH • 543220 | 56.9/100 | ₹1016.00₹1016 | ₹107422.79₹107422.79 | 73.71Average 73.7 Average | 14.33%Average 14.33% Average | 13.43%Average 13.43% Average | 0.32Excellent 0.3 Excellent | — — | 27.30%Excellent 27.30% Excellent | 0.18% |
Fortis Healthcare LimitedFortis Healthca... FORTIS • 532843 | 56.8/100 | ₹923.95₹924 | ₹73687.64₹73687.64 | 70.32Average 70.3 Average | 11.08%Average 11.08% Average | 12.83%Average 12.83% Average | 0.29Excellent 0.3 Excellent | — — | 17.76%Excellent 17.76% Excellent | 0.10% |
Aster DM Quality Care LimitedAster DM Qualit... ASTERDM • 540975 | 37.2/100 | ₹765.25₹765 | ₹71917.90₹71917.90 | 225.67Average 225.7 Average | 9.70%Poor 9.70% Poor | 11.35%Average 11.35% Average | 0.15Excellent 0.2 Excellent | 21.31%Excellent 21.31% Excellent | -11.61%Poor -11.61% Poor | 0.61% |
Narayana Hrudayalaya Ltd.Narayana Hruday... NH • 539551 | 68.3/100 | ₹1890.10₹1890 | ₹41592.95₹41592.95 | 50.96Average 51.0 Average | 19.74%Good 19.74% Good | 14.53%Average 14.53% Average | 1.07Average 1.1 Average | — — | 25.05%Excellent 25.05% Excellent | 0.22% |
Global Health LimitedGlobal Health L... MEDANTA • 543654 | 59.9/100 | ₹1404.40₹1404 | ₹35993.93₹35993.93 | 64.72Average 64.7 Average | 15.15%Good 15.15% Good | 16.85%Good 16.85% Good | 0.30Excellent 0.3 Excellent | — — | — — | 0.04% |
13.9/100 | ₹772.50₹773 | ₹33947.05₹33947.05 | 166.00Average 166.0 Average | 11.01%Average 11.01% Average | 9.35%Poor 9.35% Poor | 1.44Average 1.4 Average | 3.71%Average 3.71% Average | 24.04%Excellent 24.04% Excellent | 0.00% | |
Dr. Agarwal's Health Care LimitedDr. Agarwal's H... AGARWALEYE • 544350 | 48.5/100 | ₹500.40₹500 | ₹15618.15₹15618.15 | 105.26Average 105.3 Average | 6.84%Poor 6.84% Poor | 10.16%Average 10.16% Average | 0.08Excellent 0.1 Excellent | — — | — — | 0.00% |
Rainbow Childrens Medicare LimitedRainbow Childre... RAINBOW • 543524 | 65.5/100 | ₹1445.20₹1445 | ₹15270.28₹15270.28 | 53.51Average 53.5 Average | 17.86%Good 17.86% Good | 18.10%Good 18.10% Good | 0.00Excellent 0.0 Excellent | — — | — — | 0.23% |
60/100 | ₹298.70₹299 | ₹9829.95₹9829.95 | 52.28Average 52.3 Average | 13.41%Average 13.41% Average | 15.25%Good 15.25% Good | 0.33Excellent 0.3 Excellent | — — | — — | 0.07% | |
Top Hospital Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Apollo Hospitals Enterprise Limited share price128448.55 Cr
- Max Healthcare Institute Limited share price107422.79 Cr
- Fortis Healthcare Limited share price73687.64 Cr
- Aster DM Quality Care Limited share price71917.90 Cr
- Narayana Hrudayalaya Ltd. share price41592.95 Cr
MAITREYA MEDICARE Quarterly Performance
Latest quarterly metrics for MAITREYA — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
-5.16%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-1720.00%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
-4.32%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
N/A
Compounded annual net profit growth over 5 years
MAITREYA MEDICARE Technical Indicators
SMA 50, SMA 200, RSI and volume signals for MAITREYA — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
MAITREYA MEDICARE Financial Statements
Annual income statement, balance sheet and cash flow for MAITREYA MEDICARE (MAITREYA) — sourced from NSE/BSE filings.
Financial Results & Statements
Latest quarterly, annual and period-wise financial data for MAITREYA MEDICARE
About MAITREYA (MAITREYA MEDICARE)
MAITREYA MEDICARE (MAITREYA) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Hospital sector with a current mar...ket capitalisation of ₹83.34 (Cr). MAITREYA MEDICARE has delivered a Return on Equity (ROE) of -8.86% and a ROCE of -2.18%. The debt-to-equity ratio stands at 0.80, reflecting the company's capital structure. Investors tracking MAITREYA share price can monitor key metrics including P/E ratio, promoter holding of 73.11%, and quarterly earnings growth.
Company Details
MAITREYA Share Price: Frequently Asked Questions
What is the current share price of MAITREYA MEDICARE?
MAITREYA MEDICARE (MAITREYA) trades at ₹120.50 on NSE. Market cap ₹83.34 (Cr). Educational data only.
What is the P/E ratio of MAITREYA MEDICARE?
MAITREYA MEDICARE has a P/E of N/Ax vs industry average 48.79x.
What is the Bull Run score for MAITREYA MEDICARE?
MAITREYA MEDICARE has a Bull Run score of 6.9/100 based on 25+ financial parameters.
Does MAITREYA MEDICARE pay dividends?
MAITREYA MEDICARE has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of MAITREYA MEDICARE?
MAITREYA MEDICARE has ROE of -8.86%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of MAITREYA MEDICARE?
MAITREYA MEDICARE has debt-to-equity of 0.80.
Is MAITREYA MEDICARE a good investment?
Bull Run gives MAITREYA MEDICARE a score of 6.9/100. This is not investment advice — consult a SEBI-registered advisor.